U.S. President Donald Trump Administration Reaches Drug Pricing Deals With Nine Biotech and Pharma FirmsCoinLive·15 hours agoBGNE0.00%06160-1.02%
STOCKS | InnoCare Bio-B Falls More Than 10% Before Narrowing LossesCoinLive·1 day ago, 02:27 AMBGNE0.00%WXXWY-1.13%
STOCKS | WuXi Biologics, BeiGene Fall On Unusual TradingCoinLive·1 day ago, 01:26 AMBGNE0.00%WXXWY-1.13%
Junshi Biosciences Discloses Planned Stake Reduction by Key A-Share InvestorTip Ranks·1 day ago, 12:07 AM01877+0.06%688180+0.88%
United Imaging Healthcare Block Trade Totals 1.596 Million Shares, RMB 168 MillionCoinLive·Aug 28 at 09:53 AM688271+1.15%
05:34 ETChina's 1st Full-stack MRI-Based BCI Solution Released in Tianjinprnewswire·Aug 27 at 09:36 AM688271+1.15%
Young startups miss out on biotech venture funding rebound, MassBio saysbiopharmadive·Aug 26 at 04:38 PMARKG-0.21%BIB0.00%
China to Foster New Pillar Industries in New Energy, Robotics, BiomedicineYicai·Aug 26 at 11:25 AM159849+0.80%516930+0.20%
Junshi Biosciences terminates 2026 A-share employee stock ownership schemePUBT·Aug 26 at 10:33 AM01877+0.06%688180+0.88%
BEONE MEDICINES Interim Net Profit Up 385.8% to USD464M; ADR Gains 0.7% PremarketAASTOCKS News·Aug 26 at 10:25 AMBGNE0.00%06160-1.02%
Daiwa Slightly Raises REMEGEN TP to HKD108, Sees Multiple Catalysts in Next 12 MonthsAASTOCKS News·Aug 26 at 08:01 AM09995-1.67%688331-1.75%
Citi Raises REMEGEN TP to HKD127.7, Maintains Buy/High Risk RatingAASTOCKS News·Aug 26 at 08:01 AM09995-1.67%688331-1.75%
BeOne says FDA approves Tevimbra-based first-line regimen for HER2+ gastroesophageal cancerPUBT·Aug 25 at 02:40 PMBGNE0.00%06160-1.02%
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion StageGlobeNewswire·Aug 25 at 02:25 AMBGNE0.00%688235-1.17%
G Sachs: BeOne Medicines Ltd. 2Q Sales Slightly Beat Forecasts, Buy Rating MaintainedAASTOCKS News·Aug 24 at 08:01 AMONC-0.46%BGNE0.00%
